Arena Labs - Improving Clinician Well Being

Wake Forest University (WFU)

Status: Completed

Conditions: Mental Health Disorder

Treatments: Device: Arena Strive; Other: Control Cohort

Study type: Interventional

Funder types: Other

Identifiers

NCT05653700

IRB00090882

Details and patient eligibility

About

To determine the efficacy of the asynchronous performance coaching platform, Arena Strive at changing measures of physiological resilience, professional fulfillment, burnout, and self-valuation in full time clinicians.

Full description

This study is a prospective randomized controlled longitudinal crossover design with a per protocol analysis integrating one sensor (WHOOP, inc Platform) and one educational intervention (Arena Strive Platform). The WHOOP sensor collects data on heart rate (HR), heart rate variability (HRV), and sleep data, and will be worn by all participants in the experimental intervention. Participants will be asked to wear the biometric sensor for 12 weeks but will have optional access to the device for a total of 24 weeks.

Enrollment: 43 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Employed full time by an Atrium Health affiliated entity
• Age 18+
• Willing and able to give written informed consent for study participation
• Healthcare workers working ≥ 36 hours of clinical duties/week
• Willingness to wear WHOOP and keep it charged for the entire duration of study
• Have a smart phone for pairing with WHOOP and the Arena Strive platform

Exclusion criteria

• Current diagnosis of a sleep-related breathing disorder including obstructive sleep apnea not being treated (with or without continuous positive airway pressure (CPAP) treatment)
• Circadian rhythm sleep-wake disorders
• Narcolepsy
• Recurrent isolated sleep paralysis
• Restless legs syndrome
• Periodic Leg Movement Disorder
• Comorbid nocturia or other conditions (benign prostatic hyperplasia) resulting in frequent need to get out of bed to use the bathroom during the night (≥3 times per night average)
• Atrial Fibrillation
• Chronic obstructive pulmonary disease (COPD) other than mild, pulmonary fibrosis or severe chronic lung disease
• Sleep apnea or undergoing treatment for a sleep related illness
• Lack of availability of iPhone or Android device

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

43 participants in 2 patient groups

Arena Strive

Experimental group

Description:

The experimental intervention employed in this study will be a 12-week, multi-phased approach involving an asynchronous learning and coaching experience (6 weeks), and exploration phase (6 weeks).

Treatment:

Device: Arena Strive

Control Cohort

Other group

Description:

Participants randomized into the control cohort - survey at baseline and end of the study

Treatment:

Other: Control Cohort